New center explores exciting possibilities for treating inherited retinal diseases that lead to blindness.

Glaucoma researchers at OHSU Casey Eye Institute work cooperatively to improve glaucoma care. 

Compared to conventional methods, OCT oximetry can provide three-dimensional information on specific vessels.

Rare opportunity to study an inherited photoreceptor degeneration in a nonhuman primate model.

At the forefront of OCT to detect changes that may allow for treatment to prevent permanent vision loss.

A collaboration among OHSU cancer researchers reveals which cases of ocular melanoma are likely to spread.

Facial Nerve Center is the only place in Oregon to offer cutting edge facial reanimation surgery.

OHSU performs the first gene editing procedure in a living person in all of medicine using CRISPR technology.

Embedding clinical research in patient care leads to improvement in quality of life for patients.

OHSU Casey Eye Institute is ideally positioned to support gene therapy and its clinical trials.

The Oregon Vision Health Network is expanding our model of eye care from individual to population health.

Ultrawide-field,  AI, and new handheld devices represent next evolution of optical coherence tomography.

Data-Driven Medicine: Diagnosing retinopathy of prematurity using artificial intelligence.

Data-Driven Medicine: Leading invention in AI, telemedicine and data analytics for ophthalmology.